Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration

PURPOSE: The aim of this study was to evaluate the effects of switching to ranibizumab in patients with neovascular age-related macular degeneration (nAMD) refractory to aflibercept treatment and to identify predictive factors for switch response. METHODS: A retrospective chart review was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Marquis, Liza-Marie, Mantel, Irmela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375986/
https://www.ncbi.nlm.nih.gov/pubmed/32399582
http://dx.doi.org/10.1007/s00417-020-04730-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375986/
https://www.ncbi.nlm.nih.gov/pubmed/32399582
http://dx.doi.org/10.1007/s00417-020-04730-8

Ejemplares similares